OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19: dealing with a potential risk factor for chronic neurological disorders
Tommaso Schirinzi, Doriana Landi, Claudio Liguori
Journal of Neurology (2020) Vol. 268, Iss. 4, pp. 1171-1178
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

COVID-19 sequelae in adults aged less than 50 years: A systematic review
Sandra Willi, Renata Vidonscky Lüthold, Adam Hunt, et al.
Travel Medicine and Infectious Disease (2021) Vol. 40, pp. 101995-101995
Open Access | Times Cited: 171

Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 127

CNS implications of COVID-19: a comprehensive review
Priyanka Nagu, Arun Parashar, Tapan Behl, et al.
Reviews in the Neurosciences (2020) Vol. 32, Iss. 2, pp. 219-234
Open Access | Times Cited: 123

COVID-19 and Alzheimer’s Disease
Marcello Ciaccio, Bruna Lo Sasso, Concetta Scazzone, et al.
Brain Sciences (2021) Vol. 11, Iss. 3, pp. 305-305
Open Access | Times Cited: 101

COVID-19 and the brain
Karan Hingorani, Shivkumar Bhadola, Anna M. Cervantes‐Arslanian
Trends in Cardiovascular Medicine (2022) Vol. 32, Iss. 6, pp. 323-330
Open Access | Times Cited: 60

COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review
Marc D. Binder, Victor Mazereel, Marc Stroobants, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 57

Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia
Pardis Zarifkar, Costanza Peinkhofer, Michael E. Benros, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 48

Demyelination as a result of an immune response in patients with COVID-19
Zahra Shabani
Acta Neurologica Belgica (2021) Vol. 121, Iss. 4, pp. 859-866
Open Access | Times Cited: 50

Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases
Carl Gunnar Gottschalk, Daniel L. Peterson, Jan Armstrong, et al.
Infectious Agents and Cancer (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 20

Physical Activity in Multiple Sclerosis: Meeting the Guidelines at the Time of the COVID-19 Pandemic
Ludovico Pedullà, Carme Santoyo-Medina, Klára Novotná, et al.
Journal of Neurologic Physical Therapy (2023) Vol. 47, Iss. 2, pp. 112-121
Open Access | Times Cited: 18

Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review)
Qingchun Lei, Tingting Wu, Jin Wu, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 4
Open Access | Times Cited: 37

COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
Narjes Baazaoui, Khalid Iqbal
Journal of Alzheimer s Disease (2022) Vol. 88, Iss. 2, pp. 399-416
Open Access | Times Cited: 26

Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review
Parissa Feizi, Kanika Sharma, Shreya R. Pasham, et al.
Journal of Neuroimmunology (2022) Vol. 371, pp. 577939-577939
Open Access | Times Cited: 22

Recombinant SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Stimulate Release of Different Pro-Inflammatory Mediators via Activation of Distinct Receptors on Human Microglia Cells
Irene Tsilioni, Theoharis C. Theoharides
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6704-6714
Closed Access | Times Cited: 15

The viral hypothesis in Alzheimer’s disease: SARS-CoV-2 on the cusp
Nanyang Liu, Xuefan Jiang, Hao Li
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 14

The prolonged health sequelae “of the COVID-19 pandemic” in sub-Saharan Africa: a systematic review and meta-analysis
Melsew Setegn Alie, Getayeneh Antehunegn Tesema, Gossa Fetene Abebe, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access

Do gastrointestinal symptoms influence neurocognitive functioning in COVID-19 patients?
Kalliopi Megari, Evanthia Thomaidou, Maria Theodoratou, et al.
Journal of Clinical Neuroscience (2025) Vol. 135, pp. 111147-111147
Closed Access

COVID-19: a new emerging respiratory disease from the neurological perspective
Amr El-Sayed, Lotfi Aleya, Mohamed Kamel
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 30, pp. 40445-40459
Open Access | Times Cited: 29

Persistence of Symptoms After Discharge of Patients Hospitalized Due to COVID-19
Lili Wu, Yongxin Wu, Haiyan Xiong, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 29

Disrupted Sleep During a Pandemic
Niraj Kumar, Ravi Gupta
Sleep Medicine Clinics (2022) Vol. 17, Iss. 1, pp. 41-52
Open Access | Times Cited: 21

Sleep During the COVID-19 Pandemic
Ioanna Papagiouvanni, Serafeim‐Chrysovalantis Kotoulas, Christos Vettas, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 11, pp. 635-643
Open Access | Times Cited: 16

Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder
Theoharis C. Theoharides
Journal of Personalized Medicine (2021) Vol. 11, Iss. 9, pp. 860-860
Open Access | Times Cited: 21

Page 1 - Next Page

Scroll to top